A recent study carried out on many ovarian cancer patients showed that 3.6% displayed germline BRCA1 mutations, 3.3% germline BRCA2 mutations and 2.9% germline RAD15C mutations [3]. This evidence concerns the gene BRCA2 and ovarian carcinoma.